PMCBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30
PharmaCyte Biotech, Inc.
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026
$0.34+0.00 (+0.53%)
Close on Oct 19, 2026
- Market cap
- $3.67M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
PharmaCyte Biotech has not reported a dividend
No dividend per share appears in PharmaCyte Biotech's annual filings since fiscal 2011.